These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 26187369

  • 1. Cytomorphologic features in thyroid nodules read as "suspicious for malignancy" on cytology may predict thyroid cancers with the BRAF mutation.
    Kwon HJ, Kim EK, Kwak JY.
    Pathol Res Pract; 2015 Sep; 211(9):671-6. PubMed ID: 26187369
    [Abstract] [Full Text] [Related]

  • 2. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
    Rossi ED, Martini M, Bizzarro T, Capodimonti S, Cenci T, Lombardi CP, Pontecorvi A, Fadda G, Larocca LM.
    Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
    [Abstract] [Full Text] [Related]

  • 3. Additional BRAF mutation analysis may have additional diagnostic value in thyroid nodules with "suspicious for malignant" cytology alone even when the nodules do not show suspicious US features.
    Seo JY, Kim EK, Kwak JY.
    Endocrine; 2014 Sep; 47(1):283-9. PubMed ID: 24452872
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic value of BRAF(V600E) mutation analysis of thyroid nodules according to ultrasonographic features and the time of aspiration.
    Moon HJ, Kim EK, Chung WY, Choi JR, Yoon JH, Kwak JY.
    Ann Surg Oncol; 2011 Mar; 18(3):792-9. PubMed ID: 20945104
    [Abstract] [Full Text] [Related]

  • 5. What to do with thyroid nodules showing benign cytology and BRAF(V600E) mutation? A study based on clinical and radiologic features using a highly sensitive analytic method.
    Kim SY, Kim EK, Kwak JY, Moon HJ, Yoon JH.
    Surgery; 2015 Feb; 157(2):354-61. PubMed ID: 25616949
    [Abstract] [Full Text] [Related]

  • 6. BRAF V600E mutation analysis of thyroid nodules needle aspirates in relation to their ultrasongraphic classification: a potential guide for selection of samples for molecular analysis.
    Nam SY, Han BK, Ko EY, Kang SS, Hahn SY, Hwang JY, Nam MY, Kim JW, Chung JH, Oh YL, Shin JH.
    Thyroid; 2010 Mar; 20(3):273-9. PubMed ID: 20187782
    [Abstract] [Full Text] [Related]

  • 7. Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status.
    Kim SK, Hwang TS, Yoo YB, Han HS, Kim DL, Song KH, Lim SD, Kim WS, Paik NS.
    J Clin Endocrinol Metab; 2011 Mar; 96(3):658-64. PubMed ID: 21239517
    [Abstract] [Full Text] [Related]

  • 8. Incidence and predictive factors of inadequate fine-needle aspirates for BRAF(V600E) mutation analysis in thyroid nodules.
    Lee KH, Kim HS, Han BK, Ko EY, Ki CS, Shin JH.
    AJR Am J Roentgenol; 2014 Feb; 202(2):391-6. PubMed ID: 24450682
    [Abstract] [Full Text] [Related]

  • 9. Initial clinical experience with BRAF(V600E) mutation analysis of core-needle biopsy specimens from thyroid nodules.
    Choi SH, Baek JH, Lee JH, Choi YJ, Ha EJ, Song DE, Kim JK, Chung KW, Kim TY, Kim WB, Shong YK.
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):607-13. PubMed ID: 26215382
    [Abstract] [Full Text] [Related]

  • 10. Morphological parameters able to predict BRAF(V600E) -mutated malignancies on thyroid fine-needle aspiration cytology: Our institutional experience.
    Rossi ED, Bizzarro T, Martini M, Capodimonti S, Fadda G, Larocca LM, Schmitt F.
    Cancer Cytopathol; 2014 Dec; 122(12):883-91. PubMed ID: 25156883
    [Abstract] [Full Text] [Related]

  • 11. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
    Zhao H, Zhang ZH, Zhou B, Xiao T, Pan QJ, Guo HQ.
    Diagn Cytopathol; 2015 Oct; 43(10):786-90. PubMed ID: 26152656
    [Abstract] [Full Text] [Related]

  • 12. Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.
    Rossi M, Buratto M, Bruni S, Filieri C, Tagliati F, Trasforini G, Rossi R, Beccati MD, Degli Uberti EC, Zatelli MC.
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2354-61. PubMed ID: 22535974
    [Abstract] [Full Text] [Related]

  • 13. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.
    Chung KW, Yang SK, Lee GK, Kim EY, Kwon S, Lee SH, Park DJ, Lee HS, Cho BY, Lee ES, Kim SW.
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):660-6. PubMed ID: 17054470
    [Abstract] [Full Text] [Related]

  • 14. Proper indication of BRAF(V600E) mutation testing in fine-needle aspirates of thyroid nodules.
    Koh J, Choi JR, Han KH, Kim EK, Yoon JH, Moon HJ, Kwak JY.
    PLoS One; 2013 Nov; 8(5):e64505. PubMed ID: 23717622
    [Abstract] [Full Text] [Related]

  • 15. Testing for BRAF (V600E) Mutation in Thyroid Nodules with Fine-Needle Aspiration (FNA) Read as Suspicious for Malignancy (Bethesda V, Thy4, TIR4): a Systematic Review and Meta-analysis.
    Trimboli P, Scappaticcio L, Treglia G, Guidobaldi L, Bongiovanni M, Giovanella L.
    Endocr Pathol; 2020 Mar; 31(1):57-66. PubMed ID: 31811566
    [Abstract] [Full Text] [Related]

  • 16. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.
    Marchetti I, Lessi F, Mazzanti CM, Bertacca G, Elisei R, Coscio GD, Pinchera A, Bevilacqua G.
    Thyroid; 2009 Aug; 19(8):837-42. PubMed ID: 19534623
    [Abstract] [Full Text] [Related]

  • 17. The BRAF(V600E) mutation is associated with malignant ultrasonographic features in thyroid nodules.
    Lee EJ, Song KH, Kim DL, Jang YM, Hwang TS, Kim SK.
    Clin Endocrinol (Oxf); 2011 Dec; 75(6):844-50. PubMed ID: 21707687
    [Abstract] [Full Text] [Related]

  • 18. Value of BRAF V600E in High-Risk Thyroid Nodules with Benign Cytology Results.
    Chen X, Zhou Q, Wang F, Zhang F, Du H, Zhang Q, Wu W, Gong X.
    AJNR Am J Neuroradiol; 2018 Dec; 39(12):2360-2365. PubMed ID: 30498021
    [Abstract] [Full Text] [Related]

  • 19. Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate Surgery.
    De Napoli L, Bakkar S, Ambrosini CE, Materazzi G, Proietti A, Macerola E, Basolo F, Miccoli P.
    Thyroid; 2016 Mar; 26(3):390-4. PubMed ID: 26548748
    [Abstract] [Full Text] [Related]

  • 20. Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma".
    Jara SM, Bhatnagar R, Guan H, Gocke CD, Ali SZ, Tufano RP.
    Head Neck; 2015 Dec; 37(12):1788-93. PubMed ID: 24989827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.